Distinguished in Temporomandibular Ankylosis

Dong Huang

600 Yishan Road, 
Shanghai, CN 
Distinguished in Temporomandibular Ankylosis
600 Yishan Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Dong Huang practices in Shanghai, China. Mr. Huang is rated as a Distinguished expert by MediFind in the treatment of Temporomandibular Ankylosis. His top areas of expertise are Temporomandibular Ankylosis, Osteochondroma, Heart Attack, Osteotomy, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 92 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Temporomandibular Ankylosis.

Gender
Male

Locations

600 Yishan Road, Shanghai, 200233, China
Other Locations
1609 Xietu Road, Shanghai, 200032, China
No. 600, Yishan Road, Xuhui, China
180 Fenglin Road, 200032, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effect of Low-dose Intracoronary Reteplase During Primary Percutaneous Coronary Intervention on Myocardial Infarct Size in Patients With Acute Myocardial Infarction
Effect of Low-dose Intracoronary Reteplase During Primary Percutaneous Coronary Intervention on Myocardial Infarct Size in Patients With Acute Myocardial Infarction
Enrollment Status: Terminated
Publish Date: September 14, 2023
Intervention Type: Drug
Study Drug: Reteplase Injection
Study Phase: Phase 3
A Randomized, Parallel-controlled, Multi-center Study of the Effects of Intracoronary Recombinant HUman Prourokinase or TIrofiban on the Coronary Flow During Primary PCI for the Acute Myocardial InfartiON
A Randomized, Parallel-controlled, Multi-center Study of the Effects of Intracoronary Recombinant HUman Prourokinase or TIrofiban on the Coronary Flow During Primary PCI for the Acute Myocardial InfartiON
Enrollment Status: Completed
Publish Date: August 07, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

92 Total Publications

Electrochemical Cyclization of 2,3-Allenols.
Electrochemical Cyclization of 2,3-Allenols.
Journal: Organic letters
Published: April 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Huang's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile